<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01449604</url>
  </required_header>
  <id_info>
    <org_study_id>RAMART0111</org_study_id>
    <nct_id>NCT01449604</nct_id>
  </id_info>
  <brief_title>Stereotactic Radiation in Vestibular Schwannoma</brief_title>
  <official_title>Randomized Comparison of Steretotactic Radiosurgery and Hypofractionated Steretotactic Radiotherapy in the Treatment of Vestibular Schwannoma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ramathibodi Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ramathibodi Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether stereotactic radiosurgery (SRS)and
      stereotactic radiotherapy (SRT)are effective in the treatment of vestibular schwannoma (VS).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Vestibular schwannomas (VSs) are slow-growing tumors of the myelin-forming cells that cover
      cranial nerve VIII.The treatment options for patients with VSs include active observation,
      surgical management, and radiotherapy. However, the optimal treatment choice remain
      controversial.

      Over the past 10 years, there has been rapid progress in the application of stereotactic
      radiotherapy to the treatment of VSs. The stereotactic radiotherapy program includes single
      fraction radiosurgery (SRS) and hypofraction stereotactic radiotherapy (HSRT) are commonly
      used for VSs treatment. Since SRS and SRT techniques differ significantly enough to raise
      questions of therapeutic advantage and until now, there is no prospective, randomized study
      comparing the outcomes for patients treated using both radiotherapy techniques. We designed
      the first prospective randomized protocol to compare SRS and SRT for answer this question.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>October 2011</start_date>
  <completion_date type="Anticipated">October 2013</completion_date>
  <primary_completion_date type="Anticipated">October 2013</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>audiogram</measure>
    <time_frame>two year</time_frame>
    <description>change from baseline audiogram at 6 months,1 year and 2 year</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>number of participant with adverse event</measure>
    <time_frame>2 year</time_frame>
    <description>the new number of adverse event after radiation at 6 month,1 and 2 year</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>tumor size</measure>
    <time_frame>2 year</time_frame>
    <description>change in tumor size at 6 month, 1 year and 2 year</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Vestibular Schwannoma</condition>
  <arm_group>
    <arm_group_label>stereotactic radiosurgery</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Radio surgery single fraction 12 Gy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>stereotactic radiotherapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Stereotactic radiotherapy hypo fraction 18 Gy in 3 fraction</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>stereotactic radiotherapy</intervention_name>
    <description>Stereotactic radiotherapy, hypofraction using 18 Gray in 3 fractions</description>
    <arm_group_label>stereotactic radiotherapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>stereotactic radiosurgery</intervention_name>
    <description>Radio surgery 12 Gy</description>
    <arm_group_label>stereotactic radiosurgery</arm_group_label>
    <other_name>SRS</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  vestibular schwannoma tumor size not more than 3 cm.

        Exclusion Criteria:

          -  NF 2 patient

          -  underlying cerebrovascular disease

          -  tumor compress and efface brain stem ( Koos 4)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Putipun Puataweepong, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ramathibodi Hospital</affiliation>
  </overall_official>
  <verification_date>October 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 2, 2011</study_first_submitted>
  <study_first_submitted_qc>October 6, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 10, 2011</study_first_posted>
  <last_update_submitted>October 6, 2011</last_update_submitted>
  <last_update_submitted_qc>October 6, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 10, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ramathibodi Hospital</investigator_affiliation>
    <investigator_full_name>Putipun Puataweepong</investigator_full_name>
    <investigator_title>Assistant professor</investigator_title>
  </responsible_party>
  <keyword>Stereotactic radiotherapy</keyword>
  <keyword>SRS</keyword>
  <keyword>SRT</keyword>
  <keyword>vestibular schwannoma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neurilemmoma</mesh_term>
    <mesh_term>Neuroma, Acoustic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

